Cited by 42Antifungal resistance and susceptibilityFungal Plant Pathogen ControlFungal Infections and Studies

In Vitro Susceptibilities of Candida albicans Isolates to Antifungal Agents in Tokat, Turkey

Open access
Yenisehirli, Gulgun, Bulut, Nermin, Yenisehirli, Aydan, Bulut, Yunus·2015·Jundishapur Journal of Microbiology

Abstract

BACKGROUND: Candida albicans is the pathogenic species most commonly isolated from fungal infections. Management of these infections depends on the immune status of the host, severity of disease, and the choice of antifungal drug. In spite of the development of new antifungal drugs, epidemiological studies have shown that resistance to antifungal drugs in C. albicans strains is becoming a serious problem. OBJECTIVES: The aim of this study was to evaluate the in vitro susceptibility of C. albicans isolates to ketoconazole, fluconazole, itraconazole, voriconazole, posaconazole, amphotericin B, caspofungin, and anidulafungin. MATERIALS AND METHODS: A total of 201 C. albicans isolates were collected from clinical specimens. Antifungal susceptibility tests were performed using the Etest. RESULTS: All the tested C. albicans isolates were found to be susceptible to amphotericin B and anidulafungin. Although none of the isolates showed resistance to caspofungin, 15% of the isolates were classified as showing intermediate resistance. The resistance rates of C. albicans isolates to ketoconazole, fluconazole, itraconazole, voriconazole and posaconazole were 32%, 34%, 21%, 14% and 14%, respectively. CONCLUSIONS: Our findings indicate that resistance of C. albicans strains to azoles is more common in Tokat, Turkey. Therefore, a strategy to control the inappropriate and widespread use of antifungal drugs is urgently needed. Fungal culturing and antifungal susceptibility testing will be useful in patient management as well as resistance surveillance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5812/jjm.28057

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The pitavastatin-fluconazole interactions were not sufficient to restore fluconazole activity in several fluconazole-resistant isolates; two C. albicans and four C. auris isolates maintained their resistance profiles to fluconazole.

    “Of note, although pitavastatin was able to demonstrate broad-spectrum synergistic interactions with fluconazole, these interactions were not sufficient to restore the antifungal activity of fluconazole in several fluconazole-resistant isolates. Considering the current resistance breakpoints for azole drugs, two C. albicans and four C. auris isolates maintained their resistance profiles to fluconaz”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yenisehirli, G., Bulut, N., Yenisehirli, A., & Bulut, Y.
Affiliations
Tokat Gaziosmanpaşa Üniversitesi (TR)
Venue
Jundishapur Journal of Microbiology
Publisher
Brieflands
Published
2015-09-08
Volume
8
Issue
9
Pages
e28057-e28057
ISSN
  • 2008-3645 (ISSN-L)
  • 2008-4161
OpenAlex
W2173365940
Cited by
42
References
48
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 2
FWCI
3.11
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Jundishapur Journal of Microbiology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Gaziosmanpasa Üniversitesi
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Fungal Plant Pathogen Control
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
Candida albicans, antifungal resistance, in vitro antifungal susceptibility, azole resistance, ketoconazole, fluconazole, itraconazole, voriconazole, posaconazole, caspofungin, anidulafungin, amphotericin B, resistance monitoring, clinical isolates, Tokat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review